Skip to main content
Equibles
RVP logo

RVP · Retractable Technologies Inc · Metrics

Track RVP — free

Use RVP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RVP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.58 0.00 (-0.02%) At close · Oct 21
Rebalance outlook locked
Market Cap
$17.39M
Shares
29.94M
Volume · Oct 21 33.51K Avg daily vol (3M) 30.17K

RVP metrics

89 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.58
Market cap
$17.39M

Price action

20 metrics
Price change (1W)
-4.7%
Price change (30D)
-18.1%
Price change (3M)
-14.5%
Price change (6M)
-7.8%
Price change (YTD)
-24.5%
Price change (1Y)
-40.7%
Trailing year
Price change (5Y)
-94.2%
52-week high
$1.06
52-week low
$0.58
Change from 52-week high
-45.2%
Change from 52-week low
+0.9%
Annualized volatility
42.2%
Annualized volatility (3M)
25.1%
Beta
0.2
RSI (14D)
21.9
Price vs SMA 50
-15.4%
Price vs SMA 200
-15.6%
Avg volume (3M)
30,187
Relative volume
0.5
Average dollar volume
$20,478

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
29.94M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.5×
reciprocal yield 219.1%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 194.9%
P / book
0.2
reciprocal yield 418.9%
FCF yield
—
TTM · current market cap
Buyback yield
43.8%
P / FCF
—
P / operating cash flow
—
Earnings yield
-19.4%

Historical valuation

8 metrics
P / E historical average (3Y)
15.7×
reciprocal yield 6.4%
P / E historical average (5Y)
15.7×
reciprocal yield 6.4%
EV / revenue historical average (3Y)
0.5×
reciprocal yield 183.9%
EV / revenue historical average (5Y)
0.7×
reciprocal yield 141.4%
EV / EBIT historical average (3Y)
16.1×
reciprocal yield 6.2%
EV / EBIT historical average (5Y)
16.1×
reciprocal yield 6.2%
EV / EBITDA historical average (3Y)
15.0×
reciprocal yield 6.7%
EV / EBITDA historical average (5Y)
15.0×
reciprocal yield 6.7%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
43.8%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
-1.4%
Operating margin
-66.9%
Trailing 12 months
Net margin
-9.9%
Gross profit (TTM)
−$491,509
Operating profit (TTM)
−$22.68M
Net income (TTM)
−$3.37M
Trailing 12 months
Diluted EPS (TTM)
$-0.13
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$1.13
Gross profit per diluted share (TTM)
$-0.02
Operating profit per diluted share (TTM)
$-0.76
EBITDA per diluted share (TTM)
$-0.50
Net income per diluted share (TTM)
$-0.11
Operating cash flow per diluted share (TTM)
$-0.17
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.02
Stock compensation per diluted share (TTM)
$0.02
Book value per share
$2.48

Growth

11 metrics
Revenue growth YoY
-31.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$33.90M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
-26.1%
Revenue CAGR (5Y)
-14.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-4.6%
Return on assets
-2.4%
Debt / equity
0.0
Current ratio
4.9
EBITDA (TTM)
−$14.87M
Free cash flow (TTM)
—
Quick ratio
3.7
Interest coverage
-278.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$1.93M
Latest balance sheet
Cash & equivalents
$2.64M
Total assets
$141.69M
Total debt
$715,921

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$4.96M
Capital expenditures (TTM)
$807,130
R&D (TTM)
$682,033
SG&A (TTM)
—
Stock compensation (TTM)
$672,223
R&D / revenue
2.0%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
31
13F filer change QoQ
+1
Institutional ownership
8.9%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
4.5%
Private-fund adviser ownership
4.2%
Active holders' share change QoQ
+13.0%
Holder tenure
9.5
Price vs estimated holder cost
-51.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
2.4%

Short interest

3 metrics
Short interest
0.2%
Latest settlement · 3.8 days to cover
Days to cover
3.8d
Short-squeeze score
40 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 946563 CUSIP 76129W105 13F (30d) 4 filings 4 filers Visit website Investor relations